← BDNF

Neuroplasticity and brain health

Brain-derived neurotrophic factor (BDNF) is the protein that keeps your neurons healthy, supports memory formation, and protects against depression and cognitive decline — and exercise is the single most powerful way to increase it

BDNF (brain-derived neurotrophic factor) is a protein your brain produces to keep neurons alive, form new connections, and maintain the regions responsible for learning and memory. Think of it as fertilizer for brain cells — without enough of it, neurons shrink, circuits weaken, and mood and cognition decline [1]. Low BDNF is strongly associated with depression, anxiety, and faster cognitive aging, while higher levels support sharper memory, emotional resilience, and protection against neurodegeneration. The single most powerful way to raise BDNF is regular exercise, though diet, sleep, and certain foods and supplements also move the needle [2].

What BDNF does in the brain

BDNF belongs to the neurotrophin family — proteins that regulate the growth, survival, and function of neurons. It binds primarily to TrkB receptors, triggering cascades that protect existing neurons from dying, encourage new synaptic connections, and support neurogenesis in the hippocampus — the brain region most critical for learning and memory [1].

The hippocampus is notably vulnerable to stress and inflammation: chronic elevated cortisol physically shrinks its volume. BDNF production counteracts this, helping the hippocampus maintain structure and function. This is why BDNF is a central target in depression research: SSRIs, exercise, and other effective interventions all increase BDNF, and this increase correlates with mood improvement. Measuring serum BDNF has been proposed as a biomarker for depression severity and treatment response.

Exercise: the most evidence-backed approach

A 2022 meta-analysis of 21 randomized controlled trials involving 809 healthy subjects confirmed that both acute (single session) and long-term exercise significantly raise circulating BDNF [2]. Aerobic exercise produced particularly consistent results in women and adults over 60. Even a 20–30 minute brisk walk produces a measurable spike in blood BDNF within the following hour.

A separate Bayesian network meta-analysis published the same year, pooling 39 RCTs across 2,031 participants, ranked exercise types by BDNF impact: resistance training ranked highest, followed by HIIT, combined training, and then aerobic training alone [3]. Heavy resistance training appears to produce more acute lactate and irisin release, both of which cross the blood-brain barrier and stimulate hippocampal BDNF gene expression.

Practical target: 3–5 sessions per week combining aerobic and resistance work. Frequency and consistency matter more than any single session intensity. See our resistance training and zone 2 cardio pages for practical guidance.

Omega-3 fatty acids (DHA and EPA)

DHA — the omega-3 concentrated in wild salmon, sardines, mackerel, and herring — increases BDNF in the hippocampus and enhances TrkB signaling. A 2023 systematic review and meta-analysis of 12 RCTs (587 subjects) found omega-3 supplementation significantly raised serum BDNF levels (SMD: 0.72 pg/mL, 95% CI: 0.28–1.15, p < 0.001) [4]. Effects were stronger with DHA-dominant formulations and in people with lower baseline omega-3 status.

Dietary sources: wild salmon (1–2 servings per week), sardines, mackerel, and herring provide the most concentrated DHA. For supplementation, a quality fish oil or algal oil supplying 1–2 g of combined DHA/EPA daily is a reasonable target. See our omega-3 pages for more on choosing sources.

Lion's mane mushroom

Lion's mane (Hericium erinaceus) is the only food-based substance known to stimulate NGF (nerve growth factor), a closely related neurotrophin to BDNF, and appears to influence BDNF directly through overlapping mechanisms. An 8-week RCT in 77 overweight adults found that 550 mg of lion's mane extract significantly decreased depression, anxiety, and sleep disturbances — with a notable increase in circulating pro-BDNF (the precursor to active BDNF) in the treatment group [5]. The active compounds are hericenones in the fruiting body and erinacines in the mycelium.

See our lion's mane page for sourcing and dosage information.

Sleep and circadian timing

BDNF expression peaks during sleep and is regulated by circadian rhythms. Even a single night of poor sleep measurably lowers serum BDNF, and chronic sleep restriction compounds the reduction over time — likely a key mechanism behind the cognitive impairment that follows prolonged insomnia. Prioritizing consistent sleep timing, a dark bedroom, and avoiding stimulants after mid-afternoon supports BDNF cycles without any supplementation.

Intermittent fasting

During fasting windows of 14–16 hours, muscles and the liver produce beta-hydroxybutyrate — a ketone body that crosses the blood-brain barrier and directly activates the BDNF gene promoter. This is one proposed mechanism behind the neuroprotective effects of caloric restriction observed in animal longevity models. The effect appears modest in humans but is consistent with the broader picture: metabolic stress from fasting, exercise, and cold exposure all converge on BDNF upregulation.

What depletes BDNF

Chronic psychological stress is among the most potent suppressors — elevated cortisol directly inhibits BDNF transcription in the hippocampus. A high-sugar, ultra-processed diet reduces BDNF expression in animal models and correlates inversely with serum levels in observational human studies. Sedentary lifestyle, sleep deprivation, and heavy alcohol use all consistently lower BDNF. The pattern is coherent: whatever inflames and stresses the brain suppresses its capacity for growth and repair.

See our adrenal health page for more on managing the cortisol-BDNF relationship, and our gut-brain axis page for how gut microbiome health intersects with neurotrophin signaling.

Evidence review

BDNF and depression pathophysiology (Chakrapani et al., 2020)

Chakrapani and colleagues (PMID 33312794) synthesized the mechanistic literature on BDNF and depression in Cureus. They documented consistent meta-analytic findings that serum BDNF is significantly lower in patients with major depressive disorder compared to healthy controls. The TrkB signaling cascade, when activated by BDNF, promotes synaptogenesis, spine density, and hippocampal neurogenesis. All major classes of antidepressants — SSRIs, SNRIs, tricyclics, and MAOIs — increase BDNF as part of their mechanism, as does exercise. The paper positions BDNF as both a reliable biomarker for depression severity and a mechanistic target for treatment, though the authors note the causality question (do low BDNF levels cause depression, or does depression cause low BDNF?) remains incompletely resolved.

Exercise and BDNF in healthy subjects (Wang et al., 2022)

Wang and colleagues (PMID 35274832) pooled 21 RCTs of healthy adults (N = 809) in a meta-analysis published in Brain and Behavior. Both acute and chronic exercise significantly raised circulating BDNF. Subgroup analysis found more pronounced effects in women versus men, in subjects over 60, and with aerobic protocols compared to mixed modalities. The authors note that BDNF measurement timing relative to exercise significantly affects results — studies measuring BDNF immediately post-exercise show larger effects than those measuring at 24 hours, reflecting the transient acute spike. Overall, they conclude long-term aerobic exercise reliably raises baseline BDNF as a sustained adaptation. Limitations include heterogeneity in exercise protocols and BDNF measurement methodology across trials.

Comparing exercise modalities (Zhou et al., 2022)

Zhou and colleagues (PMID 36092802) applied Bayesian network meta-analysis to 39 RCTs (2,031 subjects) to rank five exercise modalities by BDNF effect size: resistance training (RT) > HIIT > combined training > aerobic training + resistance > aerobic training alone. The ranking of resistance training as highest is counter-intuitive relative to the prevailing assumption that aerobic exercise is primary. The proposed mechanism is that heavy resistance work generates more acute lactate and irisin (a myokine released by muscle) than moderate aerobic exercise, and both compounds directly upregulate hippocampal BDNF gene expression. The Bayesian framework allowed indirect comparisons across trials that did not directly test all modalities head-to-head, improving the inferential value of the ranking. The study is limited by variation in participant health status, exercise intensity definitions, and BDNF biomarker measurement protocols across included RCTs.

Omega-3 supplementation and BDNF (Ziaei et al., 2023)

Ziaei and colleagues (PMID 37589276) performed a systematic review and meta-analysis of 12 RCTs (587 subjects) examining the effect of omega-3 supplementation on serum BDNF. The pooled effect was a significant SMD of 0.72 pg/mL (95% CI: 0.28–1.15, p < 0.001), indicating that omega-3 supplementation meaningfully raises circulating BDNF. Heterogeneity was high (I² = 78%), reflecting variation in omega-3 formulation (EPA-dominant vs. DHA-dominant), dose (ranging from 360 mg to 4,000 mg/day), participant health status, and study duration. This meta-analysis is complemented by mechanistic animal research: DHA deficiency substantially reduces hippocampal BDNF, impairs NMDA receptor activation, and compromises long-term memory consolidation. The human clinical picture aligns directionally with these preclinical findings.

Lion's mane and pro-BDNF (Vigna et al., 2019)

Vigna and colleagues (PMID 31118969) enrolled 77 overweight and obese adults in an 8-week RCT. Participants were assigned to either 550 mg Hericium erinaceus extract plus a low-calorie diet, or low-calorie diet alone. The lion's mane group showed significant improvements in depression scores (p < 0.05), anxiety, sleep quality, and binge eating tendencies. Serum pro-BDNF — the precursor to mature, active BDNF — increased significantly in the treatment group with no corresponding rise in mature BDNF. The authors propose that H. erinaceus increases BDNF synthesis but that the enzymatic cleavage of pro-BDNF to active BDNF may require additional co-factors or longer duration. The study is limited by the small sample size and the concurrent dietary intervention, making it difficult to isolate the lion's mane effect. The pro-BDNF result is biologically meaningful given that pro-BDNF has distinct receptor affinities (favoring p75NTR over TrkB) and its increase suggests upstream BDNF pathway activation.

Overall evidence assessment

The evidence for exercise as a BDNF booster is robust — multiple meta-analyses of RCTs across diverse populations and exercise modalities consistently show the effect, with effect sizes that are practically meaningful. The omega-3 evidence is moderate, with significant pooled effects but high heterogeneity suggesting the benefit is not uniform across populations or formulations. Lion's mane evidence is preliminary — a biologically plausible single small RCT. Together, the picture is coherent: BDNF is a tractable, lifestyle-responsive target for brain health that responds to interventions most people can adopt without pharmacological assistance.

References

  1. Neuroplasticity and the Biological Role of Brain Derived Neurotrophic Factor in the Pathophysiology and Management of DepressionChakrapani S, Eskander N, De Los Santos LA, Omisore BA, Mostafa JA. Cureus, 2020. PubMed 33312794 →
  2. The effect of physical exercise on circulating brain-derived neurotrophic factor in healthy subjects: A meta-analysis of randomized controlled trialsWang YH, Zhou HH, Luo Q, Cui S. Brain and Behavior, 2022. PubMed 35274832 →
  3. Effects of different physical activities on brain-derived neurotrophic factor: A systematic review and bayesian network meta-analysisZhou B, Wang Z, Zhu L, Huang G, Li B, Chen C, Huang J, Ma F, Liu TC. Frontiers in Aging Neuroscience, 2022. PubMed 36092802 →
  4. A systematic review and meta-analysis of the omega-3 fatty acids effects on brain-derived neurotrophic factor (BDNF)Ziaei S, Mohammadi S, Hasani M, Morvaridi M, Belančić A, Daneshzad E, Saleh SAK, Adly HM, Heshmati J. Nutritional Neuroscience, 2023. PubMed 37589276 →
  5. Hericium erinaceus Improves Mood and Sleep Disorders in Patients Affected by Overweight or Obesity: Could Circulating Pro-BDNF and BDNF Be Potential Biomarkers?Vigna L, Morelli F, Agnelli GM, Napolitano F, Ratto D, Occhinegro A. Evidence-Based Complementary and Alternative Medicine, 2019. PubMed 31118969 →

Weekly Research Digest

Get new topics and updated research delivered to your inbox.